In euglycemic diabetic ketoacidosis, should 10% dextrose in water (D10W) or dextrose‑normal saline (DNS) be used as the appropriate IV solution?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Euglycemic DKA: Use 10% Dextrose with Crystalloid (0.9% NaCl or Balanced Solution)

In euglycemic DKA, you must start dextrose-containing IV fluids (typically 10% dextrose) alongside crystalloid solutions (0.9% NaCl or balanced crystalloids) from the beginning of insulin therapy to prevent hypoglycemia while correcting the severe acidosis and ketosis. 1

Why Dextrose is Essential in Euglycemic DKA

The fundamental problem in euglycemic DKA is that blood glucose is already low (<200-250 mg/dL) but severe ketoacidosis persists, requiring substantial insulin to suppress ketogenesis. Without concurrent dextrose administration, insulin will drive glucose dangerously low before the acidosis resolves.

The Algorithm

Initial Fluid Resuscitation:

  • Start with 0.9% NaCl or balanced crystalloid (lactated Ringer's, Plasma-Lyte) for volume repletion 1, 2
  • Aim to replace 50% of estimated fluid deficit in first 8-12 hours 1

When Glucose is Already in Euglycemic Range (<250 mg/dL):

  • Immediately add 10% dextrose infusion alongside the crystalloid 1, 3
  • Do NOT wait for glucose to drop further
  • Target glucose between 150-200 mg/dL for DKA resolution 1

Insulin Management:

  • Start insulin infusion at 0.1 units/kg/h (or 0.05 units/kg/h for moderate-severe DKA) 1
  • In euglycemic DKA specifically, some protocols suggest delaying insulin until glucose rises above 250 mg/dL with dextrose administration 4
  • Continue insulin until acidosis resolves (pH >7.3, bicarbonate >15-18 mmol/L, anion gap closes) 1

Key Clinical Pitfalls

Common Error #1: Stopping insulin when glucose normalizes

  • The acidosis requires continued insulin to suppress ketogenesis even after glucose normalizes
  • Solution: Increase dextrose concentration (can use 10% or even 20% dextrose) while maintaining insulin 3

Common Error #2: Not recognizing euglycemic DKA early

  • Absence of marked hyperglycemia delays diagnosis 5, 6
  • Always check blood ketones (β-hydroxybutyrate) in any diabetic patient with metabolic acidosis, regardless of glucose level 6, 7

Common Error #3: Using standard DKA protocol without modification

  • Standard protocols wait to add dextrose until glucose drops to 200-250 mg/dL
  • In euglycemic DKA, glucose is already there—start dextrose immediately 1, 4

Dextrose Concentration Guidance

  • 10% dextrose is the standard concentration mentioned in guidelines 1
  • Higher concentrations (20% dextrose) may be needed when large amounts of insulin are required to correct severe acidosis 3
  • Typical infusion rate: 50-100 mL/h, adjusted to maintain glucose 150-200 mg/dL 8

Crystalloid Choice: Normal Saline vs Balanced Solutions

Recent evidence suggests balanced crystalloids (lactated Ringer's, Plasma-Lyte) may reduce hyperchloremic acidosis compared to 0.9% NaCl 2. While both are acceptable per guidelines 1, balanced solutions offer biochemical advantages without compromising safety. The choice between them is less critical than ensuring dextrose is added appropriately.

Monitoring Requirements

  • Check glucose every 2-4 hours initially 1
  • Monitor electrolytes, pH, and ketones every 2-4 hours until stable 1
  • Blood β-hydroxybutyrate is more reliable than urine ketones for diagnosis and monitoring 6, 7

The bottom line: In euglycemic DKA, dextrose-containing fluids (DNS or D10W + crystalloid) are not optional—they are mandatory from the start to safely deliver the insulin needed to resolve ketoacidosis without causing hypoglycemia.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.